● The share is getting closer to its long-term support in weekly data, at EUR 2.28, which offers good timing for buyers.
● The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.3 for the 2019 fiscal year.
● The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
● Analysts covering this company mostly recommend stock overweighting or purchase.
● The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
● With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
● Low profitability weakens the company.
● Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
● The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
● For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
● For the last few months, analysts have been revising downwards their earnings forecast.
● Below the resistance at 2.99 EUR, the stock shows a negative configuration when looking looking at the weekly chart.